Adaptive Biotechnologies (ADPT) FCF Margin (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted FCF Margin of 13.68% for Q1 2026, down 791.08% sequentially from 1.98% in Q4 2025, and up 4303.0% YoY from 0.31% in Q1 2025.
Adaptive Biotechnologies (ADPT) FCF Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported FCF Margin for 9 years, with the latest figure at 13.68% in Q1 2026.
- Quarterly FCF Margin rose 4303.0% year-over-year to 13.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.78% (up 3579.0% YoY) and the FY2025 annual result came in at 17.67%, up 3625.0% from the prior year.
- FCF Margin declined to 13.68% in Q1 2026 per ADPT's latest filing, from 1.98% in the prior quarter.
- Over five years, FCF Margin peaked at 1.98% in Q4 2025 and troughed at 284.71% in Q2 2023.
- A 5-year average of 80.83% and a median of 57.47% in 2023 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2024: FCF Margin slumped 16449 bps in 2023, then soared 24742 bps in 2024.
- Over 5 years, FCF Margin stood at 32.48% in 2022, then slumped by 77 bps to 57.47% in 2023, then jumped by 50 bps to 28.94% in 2024, then jumped by 107 bps to 1.98% in 2025, then plunged by 791 bps to 13.68% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 13.68%, 1.98%, and 9.82% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 20.19% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -1.15% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.24% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.51% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.51% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.41% |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | -10.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.60% |
| Mar 31, 2026 | -14.58% |
| Dec 31, 2025 | 1.98% |
| Sep 30, 2025 | -8.02% |
| Jun 30, 2025 | -22.22% |
| Mar 31, 2025 | -56.71% |
| Dec 31, 2024 | -26.49% |
| Sep 30, 2024 | -59.03% |
| Jun 30, 2024 | -44.07% |
| Mar 31, 2024 | -95.20% |
| Dec 31, 2023 | -61.66% |
| Sep 30, 2023 | -130.44% |
| Jun 30, 2023 | -353.94% |
| Mar 31, 2023 | -164.89% |
| Dec 31, 2022 | -58.99% |
| Sep 30, 2022 | -100.02% |
| Jun 30, 2022 | -119.93% |
| Mar 31, 2022 | -174.86% |
| Dec 31, 2021 | -166.28% |
| Sep 30, 2021 | -147.12% |